Search results

  1. Dialysis product company NxStage Medical Inc. has entered into a strategic business alliance with Japan-based ... Sales growth no guarantee of solid stock performance.
    www.bizjournals.com/.../lawrence/nxstage_medical_inc/3267025 - Cached
    More results from bizjournals.com »
  2. Stock Watch Weekly; Forex Weekly; News To Use; ... Do It Yourself Dialysis NxStage Medical (Nasdaq:NXTM) has developed a home care solution for dialysis patients.
    www.investopedia.com/stock...in_dialysis_fmsdvanxtm.aspx - Cached
    More results from investopedia.com »
  3. All purchased NxStage Monthly Dialysis Supplies are the property of Customer or the applicable Authorized Customer Location. ... (the “Common Stock”), ...
    www.faqs.org/sec-filings/100806/NxStage-Medical-Inc_10-Q/... - Cached
    More results from faqs.org »
  4. The event highlights System One dialyzor experiences in achieving work-life-dialysis balance with NxStage therapy. ... • Rising home and stock prices boost US ...
    www.equities.com/news/healthcare/2013-03-08/1143096/... - Cached
  5. Overview page of events, news, people, companies, organizations related to NxStage Medical Inc
    news.silobreaker.com/nxstage-medical-inc-11_16364702 - Cached
  6. NxStage Medical, Inc. ... NxStage sells a line of extracorporeal disposable products for use primarily for in-center dialysis treatments for ... Stock Price. View ...
    www.crunchbase.com/company/nxstage-medical - Cached
    More results from crunchbase.com »
  7. NxStage Reports First Quarter 2013 Financial Results Highlights: - Revenue Increases to $61.6 million, up 8% from Q1'12 - Home Revenue Increases to $31.5 ...
    www.bloomberg.com/article/2013-05-02/afPtr8dVPaE4.html - Cached
    More results from bloomberg.com »
  8. Utterberg currently owns approximately 7% of NxStage common stock and his total ownership would be approximately ... position in the dialysis ...
    www.nlvpartners.com/press/press_060407_nx.html - Cached
  9. Nxstage Medical (NASDAQ ... The firm currently has an overweight rating on the stock. ... which will lead to greater use of home dialysis over the long-term.,” the ...
    zolmax.com/nxstage-medical-given-new-16-00-price-target... - Cached
  10. Xcorporeal, Inc. (AMEX: XCR) is a potential undiscovered gem in microcap and low-priced stock investing, and it is in the arena of kidney dialysis. This week’s ...
    247wallst.com/2008/03/14/microcap-featur - Cached